Effects of smoking on the lower respiratory tract microbiome in miceOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study tested how cigarette smoke changes the lower respiratory tract microbiome and lung inflammation in mice. Lung tissue was dissected directly to avoid contamination from the upper respiratory tract. Investigators used 16S rRNA gene sequencing of the V4-V5 region to compare microbial diversity and community between smoking and non-smoking mice. They also measured serum interleukin-6 and C-reactive protein by ELISA, and scored lung inflammation on hematoxylin and eosin stained sections.
Who was studied?
The model was 40 eight-week-old male Kunming mice, weighing 20-22 g, randomized into a smoking group and a non-smoking group of 20 each. The work was done in China. Smoking mice were exposed to smoke from 14 cigarettes for 2 hours per day for 90 days. Non-smoking mice received no smoke. Four mice died during the experiment, two per group, leaving 36 mice (18 per group) for analysis.
What were the most important findings?
Smoking mice gained weight more slowly and showed denser lung inflammation and congestion with higher histological scores. Serum IL-6 and CRP did not differ significantly between groups (p greater than 0.05), though both trended upward with smoke. The smoking group had significantly higher alpha diversity (PD index 37.62 plus or minus 3.56 versus 34.96 plus or minus 3.33, p less than 0.05). Proteobacteria and Firmicutes dominated both groups (about 61.6 and 24.0 percent in smokers). Enterobacter, Acidimicrobiales_norank, and Caulobacteraceae_Unclassified genera were significantly more abundant in non-smoking mice (p less than 0.001). Overall, 29 to 47 genera differed between groups.
What are the greatest implications of this study?
The findings show that smoking alters both the diversity and structure of the lower respiratory tract microbiome in mice, alongside increased lung inflammation. This supports considering microbial variation in smoking-induced lung disease. Unusually, diversity rose rather than fell with smoke, which the authors suggest may reflect increased infection risk. The study cannot say whether inflammation drives microbial change or the reverse. Limitations include a small sample and use of only male mice.